235 related articles for article (PubMed ID: 29339752)
1. Prognostic Performance of Ten Liver Function Models in Patients with Hepatocellular Carcinoma Undergoing Radiofrequency Ablation.
Ho SY; Liu PH; Hsu CY; Chiou YY; Su CW; Lee YH; Huang YH; Lee FY; Hou MC; Huo TI
Sci Rep; 2018 Jan; 8(1):843. PubMed ID: 29339752
[TBL] [Abstract][Full Text] [Related]
2. Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation.
Oh IS; Sinn DH; Kang TW; Lee MW; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
Dig Dis Sci; 2017 Nov; 62(11):3235-3242. PubMed ID: 28983724
[TBL] [Abstract][Full Text] [Related]
3. Prognostic role of noninvasive liver reserve markers in patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
Ho SY; Liu PH; Hsu CY; Hsia CY; Lee YH; Lee RC; Huang YH; Lee FY; Hou MC; Tsai YJ; Huo TI
PLoS One; 2017; 12(7):e0180408. PubMed ID: 28672011
[TBL] [Abstract][Full Text] [Related]
4. Comparison of twelve liver functional reserve models for outcome prediction in patients with hepatocellular carcinoma undergoing surgical resection.
Ho SY; Liu PH; Hsu CY; Hsia CY; Su CW; Lee YH; Huang YH; Lee FY; Hou MC; Huo TI
Sci Rep; 2018 Mar; 8(1):4773. PubMed ID: 29555927
[TBL] [Abstract][Full Text] [Related]
5. Comparison Between Child-Turcotte-Pugh and Albumin-Bilirubin Scores in Assessing the Prognosis of Hepatocellular Carcinoma After Stereotactic Ablative Radiation Therapy.
Lo CH; Liu MY; Lee MS; Yang JF; Jen YM; Lin CS; Chao HL; Shen PC; Huang WY
Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):145-152. PubMed ID: 28816140
[TBL] [Abstract][Full Text] [Related]
6. Albumin-bilirubin grade predicts the outcomes of liver resection versus radiofrequency ablation for very early/early stage of hepatocellular carcinoma.
Chong CC; Chan AW; Wong J; Chu CM; Chan SL; Lee KF; Yu SC; To KF; Johnson P; Lai PB
Surgeon; 2018 Jun; 16(3):163-170. PubMed ID: 28807570
[TBL] [Abstract][Full Text] [Related]
7. Modified CLIP with objective liver reserve assessment retains prognosis prediction for patients with advanced hepatocellular carcinoma.
Shao YY; Liu TH; Lee YH; Hsu CH; Cheng AL
J Gastroenterol Hepatol; 2016 Jul; 31(7):1336-41. PubMed ID: 26860846
[TBL] [Abstract][Full Text] [Related]
8. ALBI and PALBI grade predict survival for HCC across treatment modalities and BCLC stages in the MELD Era.
Liu PH; Hsu CY; Hsia CY; Lee YH; Chiou YY; Huang YH; Lee FY; Lin HC; Hou MC; Huo TI
J Gastroenterol Hepatol; 2017 Apr; 32(4):879-886. PubMed ID: 27696519
[TBL] [Abstract][Full Text] [Related]
9. Albumin - bilirubin (ALBI) versus Child-Turcotte-Pugh (CTP) in prognosis of HCC after stereotactic body radiation therapy.
Su TS; Yang HM; Zhou Y; Huang Y; Liang P; Cheng T; Chen L; Li LQ; Liang SX
Radiat Oncol; 2019 Mar; 14(1):50. PubMed ID: 30917853
[TBL] [Abstract][Full Text] [Related]
10. Radiofrequency ablation is better than surgical resection in patients with hepatocellular carcinoma within the Milan criteria and preserved liver function: a retrospective study using propensity score analyses.
Lee YH; Hsu CY; Chu CW; Liu PH; Hsia CY; Huang YH; Su CW; Chiou YY; Lin HC; Huo TI
J Clin Gastroenterol; 2015 Mar; 49(3):242-9. PubMed ID: 24714185
[TBL] [Abstract][Full Text] [Related]
11. Albumin-bilirubin grade may determine the outcomes of patients with very early stage hepatocellular carcinoma after radiofrequency ablation therapy.
Chen PC; Chiu NC; Su CW; Huang YH; Hou MC; Lin HC; Wu JC
J Chin Med Assoc; 2019 Jan; 82(1):2-10. PubMed ID: 30839396
[TBL] [Abstract][Full Text] [Related]
12. Tumor burden score as a new prognostic surrogate in patients with hepatocellular carcinoma undergoing radiofrequency ablation: role of albumin-bilirubin (ALBI) grade vs easy ALBI grade.
Ho SY; Liu PH; Hsu CY; Huang YH; Liao JI; Su CW; Hou MC; Huo TI
Expert Rev Gastroenterol Hepatol; 2022 Sep; 16(9):903-911. PubMed ID: 35999514
[TBL] [Abstract][Full Text] [Related]
13. Albumin-bilirubin versus Child-Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma.
Wang YY; Zhong JH; Su ZY; Huang JF; Lu SD; Xiang BD; Ma L; Qi LN; Ou BN; Li LQ
Br J Surg; 2016 May; 103(6):725-734. PubMed ID: 27005482
[TBL] [Abstract][Full Text] [Related]
14. A New Prognostic Model Based on Albumin-Bilirubin Grade for Hepatocellular Carcinoma Beyond the Milan Criteria.
Ho SY; Liu PH; Hsu CY; Hsia CY; Huang YH; Su CW; Lei HJ; Lee RC; Hou MC; Huo TI
Dig Dis Sci; 2020 Feb; 65(2):658-667. PubMed ID: 31659612
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of albumin-bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma.
Hiraoka A; Kumada T; Michitaka K; Toyoda H; Tada T; Ueki H; Kaneto M; Aibiki T; Okudaira T; Kawakami T; Kawamura T; Yamago H; Suga Y; Miyamoto Y; Tomida H; Azemoto N; Mori K; Miyata H; Ninomiya T; Kawasaki H
J Gastroenterol Hepatol; 2016 May; 31(5):1031-6. PubMed ID: 26647219
[TBL] [Abstract][Full Text] [Related]
16. Modified Child-Pugh grade
Huang F; Gao J
World J Gastroenterol; 2020 Feb; 26(7):749-758. PubMed ID: 32116422
[TBL] [Abstract][Full Text] [Related]
17. An Albumin-Bilirubin (ALBI) Grade-based Prognostic Model For Patients With Hepatocellular Carcinoma Within Milan Criteria.
Ho SY; Liu PH; Hsu CY; Hsia CY; Su CW; Huang YH; Lei HJ; He YJ; Hou MC; Huo TI
Am J Clin Oncol; 2019 Sep; 42(9):698-704. PubMed ID: 31335351
[TBL] [Abstract][Full Text] [Related]
18. Incorporating albumin-bilirubin grade into the cancer of the liver Italian program system for hepatocellular carcinoma.
Chan AW; Chong CC; Mo FK; Wong J; Yeo W; Johnson PJ; Yu S; Lai PB; Chan AT; To KF; Chan SL
J Gastroenterol Hepatol; 2017 Jan; 32(1):221-228. PubMed ID: 27257086
[TBL] [Abstract][Full Text] [Related]
19. Applicability of albumin-bilirubin-based Japan integrated staging score in hepatitis B-associated hepatocellular carcinoma.
Chan AW; Chong CC; Mo FK; Wong J; Yeo W; Johnson PJ; Yu S; Lai PB; Chan AT; To KF; Chan SL
J Gastroenterol Hepatol; 2016 Oct; 31(10):1766-1772. PubMed ID: 26992142
[TBL] [Abstract][Full Text] [Related]
20. Postoperative Albumin-Bilirubin Grade Change Predicts the Prognosis of Patients with Hepatitis B-Related Hepatocellular Carcinoma Within the Milan Criteria.
Li C; Zhang XY; Peng W; Wen TF; Yan LN; Li B; Yang JY; Wang WT; Xu MQ
World J Surg; 2018 Jun; 42(6):1841-1847. PubMed ID: 29138913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
